tradingkey.logo

KORU Medical Systems Inc

KRMD
View Detailed Chart
4.920USD
+0.050+1.03%
Close 02/06, 16:00ETQuotes delayed by 15 min
227.76MMarket Cap
LossP/E TTM

KORU Medical Systems Inc

4.920
+0.050+1.03%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.03%

5 Days

-8.72%

1 Month

-11.99%

6 Months

+50.92%

Year to Date

-15.32%

1 Year

+1.44%

View Detailed Chart

Key Insights

KORU Medical Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 79 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.60.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

KORU Medical Systems Inc's Score

Industry at a Glance

Industry Ranking
79 / 205
Overall Ranking
214 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

KORU Medical Systems Inc Highlights

StrengthsRisks
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.65M.
Undervalued
The company’s latest PE is -60.98, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 26.41M shares, decreasing 4.34% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.21M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.08.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
6.600
Target Price
+35.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

KORU Medical Systems Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

KORU Medical Systems Inc Info

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Ticker SymbolKRMD
CompanyKORU Medical Systems Inc
CEOTharby (Linda M)
Websitehttps://www.korumedical.com/
KeyAI